• Do Not Take If

    Your child should not receive any formulation of LUPRON DEPOT-PED if he/she has experienced any type of allergic reaction to LUPRON DEPOT-PED or similar drugs.

    Females who are or may become pregnant should not receive any formulation of LUPRON DEPOT-PED.

    LUPRON DEPOT-PED is not for children under 2 years of age.

    View the full Prescribing Information for LUPRON DEPOT-PED.

    Reference: LUPRON DEPOT-PED [package insert]. North Chicago, IL: Abbott Laboratories.

    202-653313
  • Before Starting

    Talk to your child's doctor about your child's medical history and all other medicines that your child takes.

    Convulsions have been observed in patients taking leuprolide acetate, including patients who have a history of seizures, epilepsy, or brain disorders (related to blood vessels, nerves, or tumors), and in patients who are taking medications that have been associated with convulsions. Convulsions have also been reported in patients without any of these conditions.

    View the full Prescribing Information for LUPRON DEPOT-PED.

    Reference: LUPRON DEPOT-PED [package insert]. North Chicago, IL: Abbott Laboratories.

    202-653313
  • What to Expect

    During the first weeks of treatment, signs of puberty, such as vaginal bleeding, may occur. This is a common initial effect of the drug. Notify your child's doctor if signs/symptoms of puberty continue beyond the second month of treatment.

    After the injection, some pain and irritation is expected; however, if more severe symptoms occur or if any new, unusual, or worsened symptoms develop, contact your child's doctor.

    Your child's initial response to LUPRON DEPOT-PED should be monitored, as well as their continued response during treatment, as clinically needed.

    • If your child receives a 1-month injection, response is assessed 1–2 months after the initial injection.
    • If your child receives a 3-month injection, response is assessed 2–3 months after the initial injection and at month 6.
    • Height and bone age should be checked every 6–12 months in children using either formulation of LUPRON DEPOT-PED.

    It is important that you keep your child's doctor appointments and follow the prescribed injection schedule. Your child's pubertal development could begin again if injections are missed.

    View the full Prescribing Information for LUPRON DEPOT-PED.

    Reference: LUPRON DEPOT-PED [package insert]. North Chicago, IL: Abbott Laboratories.

    202-653313
  • Side Effects

    The most common side effects with LUPRON DEPOT-PED and similar drugs are pain; acne; injection site reactions, including pain, swelling, and abscess; rash, including a painful rash with fever, blisters/sores, and facial swelling; vaginitis/vaginal bleeding/vaginal discharge; increased weight; altered mood; general pain; headache; fluctuating emotions; and hot flushes/sweating.

    View the full Prescribing Information for LUPRON DEPOT-PED.

    Reference: LUPRON DEPOT-PED [package insert]. North Chicago, IL: Abbott Laboratories.

    202-653313
  • Helpful Resources

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

    If you cannot afford your medication, contact www.pparx.org or call the toll-free phone number (1-888-4PPANOW) for assistance.

    View the full Prescribing Information for LUPRON DEPOT-PED.

    Reference: LUPRON DEPOT-PED [package insert]. North Chicago, IL: Abbott Laboratories.

    202-653313
Print Safety Facts

LUPRON DEPOT-PED 7.5 mg, 11.25 mg and 15 mg for 1-month and 11.25 mg and 30 mg for 3-month administration are prescribed for the treatment of children with central precocious puberty (CPP).

Doctors may diagnose children with CPP when signs of sexual maturity begin to develop in girls under the age of 8 or boys under the age of 9. Your doctor should perform tests to rule out possible causes of CPP that would require different treatment (e.g., tumors).

LUPRON DEPOT-PED must be administered under the supervision of a physician.

Glossary of terms

Adolescence: the period of life starting with the appearance of secondary sex characteristics and ending with the ceasing of the body's overall growth

Bone age: the stage of development of the skeleton as compared with x-ray views of bone structures of other individuals who are the same age

Central precocious puberty (CPP): a condition in which the physical and hormonal signs of puberty develop in children at an earlier age than is considered normal. CPP is caused by the early release of hormones by the brain.

Chronological age: a person's actual age in terms of years and months

CPP: see central precocious puberty

Estrogen: female sex hormone responsible for the development of secondary sex characteristics and involved in the reproductive cycle in women

Follicle-stimulating hormone (FSH): a hormone released by the pituitary gland that stimulates the ovaries to produce estrogen and the testicles to produce testosterone—which lead to the changes you see during puberty

FSH: see follicle-stimulating hormone

GnRH: see gonadotropin-releasing hormone

Gonadotropin-releasing hormone (GnRH): a hormone made by the hypothalamus (part of the brain) that causes the pituitary gland (a small gland at the base of the brain) to release two other hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH)

Gonadotropin-releasing hormone (GnRH) agonist: The most common treatment for CPP. GnRH agonists work by making sure the pituitary gland stops sending hormones to stimulate the ovaries and testes to produce sex hormones.

Hormone: a chemical substance produced in an organ of the body (like the adrenal glands or the pituitary gland) and carried to another organ or tissue in the body, where it has a specific effect

Hypothalamus: a part of the brain that regulates a number of basic body functions, like temperature, sleep, food intake, and the development of secondary sex characteristics

LH: see luteinizing hormone

Luteinizing hormone (LH): a hormone released by the pituitary gland that stimulates the ovaries to produce estrogen and the testicles to produce testosterone—which lead to the changes you see during puberty

Pediatric endocrinologist: a doctor who specializes in the treatment of hormone-related conditions in children

Pituitary gland: a small gland located at the base of the brain that helps control the release of hormones

Precocious: maturity that is unusually early for a person of that age; showing premature development

Puberty: the period when a person begins to develop secondary sex characteristics and becomes capable of sexual reproduction

Tanner stage: a stage of puberty as set out on the Tanner growth chart, based on the growth of pubic hair in both sexes, the development of the genitalia in boys, and the development of the breasts in girls2

Testosterone: male sex hormone (a small amount is produced by females as well) that is responsible for producing masculine secondary sex characteristics such as growth of body hair and the development of the male reproductive system.

References: 1. Dorland’s illustrated medical dictionary. 28th ed. Philadelphia: W.B. Saunders Co.; 1988:445. 2. Muir A. Precocious puberty. Pediatr Rev. 2006;27:373-381.
Back to the Top ^

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you cannot afford your medication, contact www.pparx.org or call the toll-free number 1-888-477-2669.

Important Safety Information

Glossary of Terms

Site Map

Prescribing Information

Contact Us

Privacy Policy

Terms of Use

Copyright ©2012 Abbott Laboratories, Abbott Park, Illinois, U.S.A. 202-653313